A self-reported survey on oral health problems in patients with inflammatory bowel disease with a stoma

C.X.W. Tan, H.S. Brand, S. Iqbal, N.K.H. de Boer, T. Forouzanfar, J.G.A.M. de Visscher

Research output: Contribution to JournalArticleAcademicpeer-review


Objectives: Patients with inflammatory bowel disease have an increased risk of developing oral health problems. The aim of this study was to investigate whether oral diseases in these patients are related to inflammation of the intestine and if there is a correlation between inflammatory bowel disease–specific health-related quality of life (IBD-HR-QOL) and oral health problems. Study Design: The study was a cross-sectional survey and analysis of self-reported oral health of individuals with a stoma for Crohn's disease (CD), ulcerative colitis (UC), and treated colon cancer (CC). Validated international questionnaires were sent to members of the Stoma Federation of The Netherlands. Because there was an unequal distribution of male and female patients with CD and CC, data of 169 age-matched female patients with CD, UC, and CC with a stoma were analyzed. Results: Patients with CD had significantly more oral health problems compared with those with UC or CC. Patients with CD and UC both had significantly more gingival-related problems compared with patients with CC. There was a significant negative correlation between IBD-HR-QOL and oral health problems. Conclusions: In the 3 distinguishable groups of patients with a stoma, patients with CD had an increased risk for oral health problems, independently from surgical removal of (a part of) the inflamed intestine, suggesting a general increased susceptibility of patients with CD for oral health problems.

Original languageEnglish
Pages (from-to)e80-e86
Number of pages7
JournalOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Issue number3
Publication statusPublished - Sept 2020


We would like to thank the Stoma Federation of The Netherlands and their members for their assistance in this study. Part of the manuscript was presented at the 23rd International Conference on Oral and Maxillofacial Surgery 2017, in Hong Kong. N.K.H. de Boer served as a speaker for AbbVie and MSD and as a consultant and/or principal investigator for TEVA Pharma VB and Takeda.

FundersFunder number
Meso Scale Diagnostics


    Dive into the research topics of 'A self-reported survey on oral health problems in patients with inflammatory bowel disease with a stoma'. Together they form a unique fingerprint.

    Cite this